Active Recombinant Human NRXN3 Protein, Fc Chimera

• Cat.No.: NRXN3-819H
• Product Overview: Recombinant Human NRXN3 (Accession # NP_620426), fused with , was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Species: Human
• Source: Mammalian Cells
• Tag: Fc
• Predicted N Terminal: Ser35
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its binding ability in a functional ELISA.Biotinylated rrNLGN-1v2 immobilized on a streptavidin-coated plate at 2 µg/mL (100 µL/well) can bind rhNeurexin 3 beta/Fc Chimera with an apparent KD < 40 nM.
• Molecular Mass: Recombinant Human NRXN3, Fc Chimera has a calculated MW of 61.1 kDa (monomer). In SDS-PAGE migrates as 85-96 kDa, reducing conditions.
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: NRXN3 neurexin 3 [ Homo sapiens ]
• Official Symbol: NRXN3
• Synonyms: NRXN3; neurexin 3; C14orf60, chromosome 14 open reading frame 60; neurexin-3-beta; KIAA0743; neurexin III; neurexin III-beta; neurexin III-alpha; C14orf60; MGC176711
• Gene ID: 9369
• mRNA Refseq: NM_001105250
• Protein Refseq: NP_001098720
• MIM: 600567
• UniProt ID: Q9HDB5
• Chromosome Location: 14q31